Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| pericyte | 40 studies | 55% ± 18% | |
| fibroblast | 34 studies | 33% ± 15% | |
| endothelial cell | 33 studies | 34% ± 13% | |
| smooth muscle cell | 29 studies | 43% ± 15% | |
| endothelial cell of lymphatic vessel | 24 studies | 52% ± 19% | |
| connective tissue cell | 13 studies | 40% ± 18% | |
| vein endothelial cell | 12 studies | 39% ± 15% | |
| basal cell | 10 studies | 30% ± 13% | |
| myofibroblast cell | 8 studies | 46% ± 16% | |
| ciliated cell | 6 studies | 38% ± 13% | |
| endothelial cell of vascular tree | 6 studies | 29% ± 23% | |
| epithelial cell | 6 studies | 38% ± 15% | |
| capillary endothelial cell | 5 studies | 24% ± 4% | |
| abnormal cell | 4 studies | 33% ± 21% | |
| GABAergic neuron | 4 studies | 25% ± 4% | |
| goblet cell | 4 studies | 22% ± 5% | |
| kidney distal convoluted tubule epithelial cell | 3 studies | 31% ± 4% | |
| epithelial cell of proximal tubule | 3 studies | 23% ± 9% | |
| kidney loop of Henle epithelial cell | 3 studies | 25% ± 5% | |
| endothelial cell of sinusoid | 3 studies | 48% ± 26% | |
| muscle cell | 3 studies | 45% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 99% | 9006.69 | 243 / 245 | 100% | 49.93 | 500 / 502 |
| kidney | 99% | 10708.35 | 88 / 89 | 99% | 73.03 | 888 / 901 |
| stomach | 100% | 11493.91 | 358 / 359 | 98% | 42.21 | 279 / 286 |
| breast | 100% | 11018.33 | 459 / 459 | 97% | 59.92 | 1086 / 1118 |
| ovary | 100% | 39466.93 | 180 / 180 | 97% | 43.58 | 417 / 430 |
| intestine | 98% | 7236.62 | 950 / 966 | 98% | 33.62 | 515 / 527 |
| lung | 99% | 9976.25 | 575 / 578 | 94% | 28.28 | 1080 / 1155 |
| bladder | 100% | 7862.71 | 21 / 21 | 90% | 26.18 | 455 / 504 |
| thymus | 100% | 8649.15 | 650 / 653 | 89% | 19.62 | 538 / 605 |
| uterus | 100% | 21460.01 | 170 / 170 | 83% | 31.38 | 382 / 459 |
| adrenal gland | 98% | 7023.33 | 254 / 258 | 83% | 20.94 | 192 / 230 |
| esophagus | 86% | 8892.62 | 1241 / 1445 | 93% | 34.53 | 170 / 183 |
| skin | 78% | 4319.74 | 1411 / 1809 | 95% | 38.06 | 447 / 472 |
| liver | 66% | 2104.42 | 149 / 226 | 86% | 22.48 | 350 / 406 |
| pancreas | 43% | 1294.62 | 142 / 328 | 98% | 45.07 | 174 / 178 |
| spleen | 100% | 15468.58 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 18.87 | 1 / 1 |
| adipose | 100% | 14758.47 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 17959.39 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 85% | 14.57 | 68 / 80 |
| heart | 83% | 3916.99 | 715 / 861 | 0% | 0 | 0 / 0 |
| brain | 16% | 564.19 | 413 / 2642 | 56% | 12.19 | 393 / 705 |
| muscle | 71% | 2389.08 | 569 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 69% | 18.15 | 31 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 52% | 7.13 | 15 / 29 |
| peripheral blood | 2% | 104.80 | 21 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0032355 | Biological process | response to estradiol |
| GO_0001893 | Biological process | maternal placenta development |
| GO_0007519 | Biological process | skeletal muscle tissue development |
| GO_0060838 | Biological process | lymphatic endothelial cell fate commitment |
| GO_0030900 | Biological process | forebrain development |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0030522 | Biological process | intracellular receptor signaling pathway |
| GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
| GO_0009956 | Biological process | radial pattern formation |
| GO_0060707 | Biological process | trophoblast giant cell differentiation |
| GO_0001937 | Biological process | negative regulation of endothelial cell proliferation |
| GO_0009566 | Biological process | fertilization |
| GO_0003084 | Biological process | positive regulation of systemic arterial blood pressure |
| GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
| GO_0060674 | Biological process | placenta blood vessel development |
| GO_0030154 | Biological process | cell differentiation |
| GO_1904936 | Biological process | interneuron migration |
| GO_0009952 | Biological process | anterior/posterior pattern specification |
| GO_0010596 | Biological process | negative regulation of endothelial cell migration |
| GO_0048514 | Biological process | blood vessel morphogenesis |
| GO_0048856 | Biological process | anatomical structure development |
| GO_0045736 | Biological process | negative regulation of cyclin-dependent protein serine/threonine kinase activity |
| GO_0008585 | Biological process | female gonad development |
| GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0005634 | Cellular component | nucleus |
| GO_0042803 | Molecular function | protein homodimerization activity |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0043565 | Molecular function | sequence-specific DNA binding |
| GO_0004879 | Molecular function | nuclear receptor activity |
| GO_0003700 | Molecular function | DNA-binding transcription factor activity |
| GO_0001972 | Molecular function | retinoic acid binding |
| GO_0008270 | Molecular function | zinc ion binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | NR2F2 |
| Protein name | COUP transcription factor 2 (COUP transcription factor II) (Nuclear receptor subfamily 2 group F member 2) Nuclear receptor subfamily 2 group F member 2 COUP transcription factor 2 (COUP-TF2) (Apolipoprotein A-I regulatory protein 1) (ARP-1) (COUP transcription factor II) (COUP-TF II) (Nuclear receptor subfamily 2 group F member 2) |
| Synonyms | TFCOUP2 ARP1 |
| Description | FUNCTION: Ligand-activated transcription factor. Activated by high concentrations of 9-cis-retinoic acid and all-trans-retinoic acid, but not by dexamethasone, cortisol or progesterone (in vitro). Regulation of the apolipoprotein A-I gene transcription. Binds to DNA site A. May be required to establish ovary identity during early gonad development . . |
| Accessions | ENST00000394171.6 [P24468-3] H3BTC2 P24468 ENST00000421109.6 [P24468-2] ENST00000559679.1 ENST00000453270.2 [P24468-3] ENST00000394166.8 [P24468-1] F1D8R0 |